vs

Side-by-side financial comparison of CME Group (CME) and THOMSON REUTERS CORP (TRI). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.8B, roughly 1.1× THOMSON REUTERS CORP). THOMSON REUTERS CORP runs the higher net margin — 17.5% vs 0.1%, a 17.5% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 2.6%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

The second and current incarnation of News Corporation, doing business as News Corp, is an American mass media and publishing company headquartered at 1211 Avenue of the Americas in Midtown Manhattan, New York City. The company was formed on June 28, 2013, as a spin-off of the first News Corporation, whose legal successor was 21st Century Fox, which held its media and entertainment assets. Operating across digital real estate information, news media, book publishing, and cable television, New...

CME vs TRI — Head-to-Head

Bigger by revenue
CME
CME
1.1× larger
CME
$1.9B
$1.8B
TRI
Growing faster (revenue YoY)
CME
CME
+11.9% gap
CME
14.5%
2.6%
TRI
Higher net margin
TRI
TRI
17.5% more per $
TRI
17.5%
0.1%
CME

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
CME
CME
TRI
TRI
Revenue
$1.9B
$1.8B
Net Profit
$1.2M
$313.0M
Gross Margin
Operating Margin
0.1%
24.4%
Net Margin
0.1%
17.5%
Revenue YoY
14.5%
2.6%
Net Profit YoY
20.7%
-62.8%
EPS (diluted)
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
TRI
TRI
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
$1.8B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
$1.7B
Net Profit
CME
CME
TRI
TRI
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$1.0B
$313.0M
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
$841.0M
Operating Margin
CME
CME
TRI
TRI
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
24.4%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
23.9%
Net Margin
CME
CME
TRI
TRI
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
60.6%
17.5%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
48.3%
EPS (diluted)
CME
CME
TRI
TRI
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
$0.69
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42
$1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
TRI
TRI
Cash + ST InvestmentsLiquidity on hand
$2.4B
$664.0M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$12.6B
Total Assets
$202.0B
$18.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
TRI
TRI
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
$664.0M
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
$1.7B
Total Debt
CME
CME
TRI
TRI
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
TRI
TRI
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$27.7B
$12.6B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
$11.6B
Total Assets
CME
CME
TRI
TRI
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$179.9B
$18.0B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B
$18.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
TRI
TRI
Operating Cash FlowLast quarter
$746.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.38×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
TRI
TRI
Q1 26
Q4 25
$1.1B
Q3 25
$968.1M
Q2 25
$1.1B
$746.0M
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$776.9M
$705.0M
Free Cash Flow
CME
CME
TRI
TRI
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
CME
CME
TRI
TRI
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
CME
CME
TRI
TRI
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
CME
CME
TRI
TRI
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
1.03×
2.38×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×
0.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons